Statistics for RBD-specific polyclonal F(ab´)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Total visits
| views | |
|---|---|
| RBD-specific polyclonal F(ab´)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial | 3 |
Total visits per month
| views | |
|---|---|
| mayo 2024 | 1 |
| junio 2024 | 2 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
File Visits
| views | |
|---|---|
| j.eclinm.2021.100843 .pdf | 4 |
| mmc1.docx | 2 |